Target intelligence / Profile preview

Enteric bacterial pathogens

Molecular classification
Other (refers to multiple bacterial species and genera)
01

Overview

Enteric bacterial pathogens are diverse Gram-negative and Gram-positive bacteria capable of causing gastrointestinal infections. This group primarily includes species such as *Salmonella*, *Escherichia coli* (pathogenic strains), *Shigella*, *Campylobacter*, *Yersinia*, *Vibrio*, and *Clostridium difficile*. These organisms are commonly associated with foodborne disease and nosocomial infections. Pathogenesis mechanisms vary and include toxin production, invasion of host cells, disruption of intestinal barrier function, and activation of host immune responses. Disease severity depends on the pathogen's virulence factors, host immunity, and exposure route. Due to widespread antibiotic resistance and high rates of morbidity, enteric bacterial pathogens pose significant public health challenges.

Other names
enteric bacteriaenteric pathogensenteric microbesintestinal pathogensgut pathogens
02

Mechanism of action

Inhibition of cell wall synthesis; Inhibition of protein synthesis; Inhibition of DNA replication; Disruption of metabolic pathways

03

Biological functions

InfectionHost colonizationToxin productionDisruption of gut barrier function
04

Disease associations

Infection (foodborne and waterborne disease, gastroenteritis, diarrhea, urinary tract infection, sepsis)
05

Safety considerations

Antibiotic resistance (carbapenem-resistant Enterobacteriaceae, MDR Salmonella, MR Shigella)Nosocomial transmissionFood safety risksSevere complications (Hemolytic uremic syndrome with EHEC, severe dehydration, systemic sepsis)
06

Interacting drugs

Antibiotics (classes: penicillins, cephalosporins, carbapenems, fluoroquinolones, aminoglycosides)

3 more in the full profile.

07

Biomarkers

Bacterial culture (e.g., stool, urine, blood)PCR detection of pathogen DNA/RNAAntigen/serotype detection (O, H, K antigens for Enterobacteriaceae)

Beyond the preview

Go deeper on Enteric bacterial pathogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteric bacterial pathogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call